BONESUPPORT Completes Trial Enrollment


Enrollment is complete in BONESUPPORT's FORTIFY study on CERAMENT® G orthobiologic, with 198 subjects enrolled.

BONESUPPORT recently requested a study protocol amendment to reduce the sample size by approximately 30 subjects due to anticipated enrollment challenges during the COVID-19 pandemic. A blinded sample size review by an...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us